Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 62% ± 13% | |
lung | 19 studies | 56% ± 18% | |
brain | 15 studies | 35% ± 15% | |
intestine | 12 studies | 54% ± 23% | |
kidney | 9 studies | 58% ± 15% | |
eye | 9 studies | 38% ± 16% | |
bone marrow | 6 studies | 58% ± 12% | |
lymph node | 6 studies | 60% ± 13% | |
liver | 6 studies | 58% ± 18% | |
pancreas | 5 studies | 65% ± 20% | |
uterus | 5 studies | 63% ± 17% | |
placenta | 4 studies | 67% ± 22% | |
prostate | 4 studies | 65% ± 13% | |
breast | 4 studies | 67% ± 3% | |
heart | 3 studies | 32% ± 12% | |
adrenal gland | 3 studies | 58% ± 15% | |
esophagus | 3 studies | 62% ± 26% | |
skin | 3 studies | 52% ± 11% | |
thymus | 3 studies | 75% ± 22% | |
adipose | 3 studies | 29% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4730.06 | 1445 / 1445 | 100% | 50.23 | 183 / 183 |
liver | 100% | 3144.62 | 226 / 226 | 100% | 50.00 | 406 / 406 |
ovary | 100% | 4636.13 | 180 / 180 | 100% | 72.95 | 430 / 430 |
uterus | 100% | 5297.99 | 170 / 170 | 100% | 63.90 | 459 / 459 |
brain | 100% | 7563.42 | 2640 / 2642 | 100% | 86.38 | 705 / 705 |
breast | 100% | 7365.13 | 459 / 459 | 100% | 95.03 | 1117 / 1118 |
thymus | 100% | 4577.31 | 653 / 653 | 100% | 46.47 | 603 / 605 |
lung | 100% | 5339.64 | 576 / 578 | 100% | 61.43 | 1155 / 1155 |
prostate | 100% | 4633.97 | 244 / 245 | 100% | 52.00 | 501 / 502 |
kidney | 100% | 5350.08 | 89 / 89 | 99% | 38.46 | 894 / 901 |
bladder | 100% | 4309.05 | 21 / 21 | 99% | 51.69 | 499 / 504 |
adrenal gland | 100% | 5402.16 | 258 / 258 | 99% | 50.29 | 227 / 230 |
stomach | 100% | 4016.65 | 359 / 359 | 99% | 51.32 | 282 / 286 |
intestine | 100% | 5646.30 | 966 / 966 | 98% | 51.36 | 518 / 527 |
skin | 100% | 5172.39 | 1805 / 1809 | 97% | 38.32 | 457 / 472 |
pancreas | 97% | 2085.29 | 317 / 328 | 99% | 40.25 | 177 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 59.46 | 29 / 29 |
spleen | 100% | 7026.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 56.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.18 | 1 / 1 |
adipose | 100% | 6510.75 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 4663.51 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6010.94 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 4809.23 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 18.50 | 65 / 80 |
peripheral blood | 72% | 5510.37 | 670 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060261 | Biological process | positive regulation of transcription initiation by RNA polymerase II |
GO_0001111 | Biological process | RNA polymerase II promoter clearance |
GO_1905463 | Biological process | negative regulation of DNA duplex unwinding |
GO_0051053 | Biological process | negative regulation of DNA metabolic process |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
Gene name | SUB1 |
Protein name | SUB1 regulator of transcription Activated RNA polymerase II transcriptional coactivator p15 (SUB1 homolog) Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (p14) |
Synonyms | RPO2TC1 PC4 hCG_1781938 |
Description | FUNCTION: General coactivator that functions cooperatively with TAFs and mediates functional interactions between upstream activators and the general transcriptional machinery. May be involved in stabilizing the multiprotein transcription complex. Binds single-stranded DNA. Also binds, in vitro, non-specifically to double-stranded DNA (ds DNA). . FUNCTION: General coactivator that functions cooperatively with TAFs and mediates functional interactions between upstream activators and the general transcriptional machinery. May be involved in stabilizing the multiprotein transcription complex. Binds single-stranded DNA. Also binds, in vitro, non-specifically to double-stranded DNA (ds DNA). . |
Accessions | ENST00000506237.5 P53999 ENST00000515355.5 ENST00000512913.5 ENST00000511615.5 ENST00000510442.1 D6RC37 D6R970 ENST00000265073.9 Q6IBA2 ENST00000502897.5 |